GC Therapeutics
Maura McInerney is a seasoned finance professional with extensive experience as a CFO Consultant across various sectors. Currently serving as a CFO Consultant at Moonlight Bio and GC Therapeutics, Maura focuses on innovative applications of synthetic biology and therapeutic strategies. Additionally, Maura is a Partner at TechCXO, providing strategic consulting services to technology companies. Prior consulting roles include work with Anna's Taqueria, Viralogic Therapeutics, Sonde Health, Boston Materials, coUrbanize, Unison Computing, and Wise Systems. Maura holds a Bachelor's Degree in Finance and Quantitative Methods from Babson College.
This person is not in any teams
This person is not in any offices
GC Therapeutics
1 followers
GC Therapeutics Inc. (GCTx) uses synthetic biology to program patient-derived stem cells into any cell type with best-in-class efficiency (up to 10X), speed (up to 100X) and scalability. We dictate cells fates in a single step and have validated cells for many applications. We have also developed SuperCells™ by tailoring cells for specific diseases. The core technology of GCTx was conceived, invented and perfected in Professor George Church’s lab at Harvard Medical School. We are a group of passionate biologists and tissue engineers whose goal is to bring this breakthrough approach to patients.